PF-08049820: Clinical Trials

4 completed. 4 Phase 1.

By phase and status

Phase	Trials	Status
Phase 1	4	Completed 4

Follow PF-08049820: new trials by email Literature Review of PF-08049820 trials Research Report on PF-08049820

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults PF-08049820, Rabeprazole - Healthy Adults, Healthy	Phase 1	Completed	Pfizer	24	2026-05-13	2026-10-01
A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Medicine PF-08049820 in Healthy Chinese Adults. PF-08049820, Rabeprazole - Healthy Adults	Phase 1	Completed	Pfizer	18	2025-11-03	2026-09-09
A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants PF-08049820, Midazolam, Dabigatran Etexilate - Atopic Dermatitis	Phase 1	Completed	Pfizer	16	2025-10-03	2026-09-09
A Study to Learn How Different Amounts of the Study Medicine Called PF-08049820 Are Tolerated and Act in the Body in Healthy Adults PF-08049820, Placebo - Healthy	Phase 1	Completed	Pfizer	71	2024-11-27	2026-09-08

Conditions studied

Dermatitis, Atopic (3)

Sponsors

Pfizer (4)

Countries

United States (3)  ·  China (1)